Back to Rankings

RGEN

RepligenC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
RGEN vs peer average
52/100
RGEN vs. peer average (C vs. C)
Grade spread
B 3 · C 3 · D 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

DHR is the first available peer comparator.

Danaher, through Cytiva and Pall, is a broader bioprocessing-tools benchmark across filtration and chromatography; it is useful for demand-cycle and margin comparisons, though it is less pure-play than Repligen.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerDHRDanaher
RGEN
Repligen
DHR
Danaher
Grade
C
D
Momentum
56
43
Value
59
62
Sentiment
42
29
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs DHR

RGEN / DHR
Grade Position
In line
RGEN vs. peer average (C vs. C)
52/100
Momentum
56
RGEN
Value
59
DHR
Sentiment
42
RGEN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGEN
1
DHR
DHR
D
40/100
+1
2
TMO
TMO
B
80/100
-1
3
IMVT
Immunovant Inc Common
C
60/100
Even
4
TGTX
TG Therapeutics Inc Common
C
60/100
Even
5
BIO
Bio-Rad Laboratories Inc Class A Common
D
40/100
+1
DHR is the first peer returned for this comparison set.